Dr. Gal Goldstein is a leading specialist in Pediatric Oncology and Hemato-Oncology at Hadassah Medical Center. He is the Head of the Pediatric Oncology and Hemato-Oncology Department at Hadassah Hospital Ein Kerem.
Dr. Goldstein has over 20 years of experience. He focuses on retinoblastoma, precision medicine, and haploidentical bone marrow transplantation. He graduated from Tel Aviv University. In 2019-2020, Forbes named him one of the best doctors in Israel.
Dr. Goldstein is a member of The Israel Society of Pediatric Hematology and Oncology, The Israeli Cancer Association, and The International Society of Pediatric Oncology. He is dedicated to advancing pediatric cancer care.
Dr. Alon Pikarsky is a board-certified general and colorectal surgeon at Hadassah Medical Center. He received his Israel Board Certification in General Surgery in 1998. He has led the Medical Students Program in Surgery since 1997. Since 2000, he has also served as Residency Program Director.
Dr. Pikarsky is known for his academic leadership. He has worked as an instructor in surgery since 1995, a lecturer since 1999, and a senior lecturer since 2005. He is an active member of several surgical associations. Dr. Pikarsky speaks both English and Hebrew fluently.
Specialization
Education and advanced training courses
Professional biography
After completing his internship, he worked as a physician in a refugee camp (Kampala, Uganda) under the auspices of the Global Youth Movement for Africa (2007). He returned to Hadassah, where he worked in the orthopedic department during his residency.
From 2013 to 2014, he was an attending spine surgeon at the Bronx Hospital (New York). After returning to Israel, he currently works as a spine surgeon in the orthopedic department.
He actively uses robotic equipment and, together with the clinic’s team of doctors, has performed many complex operations to restore the structure of the spinal column.
Scientific activity
Participated in various clinical studies in California, Switzerland, and the USA. Teaches at the University of Jerusalem and Cornell Weill University, is a member of the Association of Orthopedists and the Congress of Vertebrologists (Milan). Has repeatedly received grants for research in the field of vertebrology. In 2017, he received an associate professor degree. Has a number of articles published in scientific journals.
Dr. Vladimir Goldman is a leading orthopedic surgeon in Israel. He heads the Limb Lengthening and Deformity Correction Department. Dr. Goldman is the only doctor in the country using the latest Stride magnetic nail technology. This method allows limb lengthening of up to 8 cm and lowers the risk of complications and infections.
He specializes in limb lengthening and deformity correction for children and adults. Dr. Goldman uses advanced internal and external fixation methods, including the Ilizarov technique. He has broad experience treating complex fractures, bone defects, and congenital conditions such as clubfoot and cerebral palsy.
Dr. Goldman graduated from the Hebrew University of Jerusalem. He completed advanced training at the Hospital for Special Surgery in New York. He has received recognition for his achievements. Dr. Goldman is a member of the Israeli Society of Pediatric Orthopedics and the North American Society for Limb Lengthening and Deformity Correction.
1998–2000 — Conducted research on the genesis of cancer at The Royal Marsden Hospital (England).
Authored numerous peer-reviewed articles in scientific journals. Selected topics include:
Oncotype Dx Recurrence Score in BRCA1/2 germline mutation carriers with hormone receptor-positive breast cancer.
TP53 missense mutation recurrence in cancer patients of Arab descent.
Adjuvant autologous vaccine for stage III microscopic melanoma: biomarker survival and enhanced response to CTLA-4 blockade.
Prognostic significance of (R)CA15-3 assay in primary breast cancer.
Diagnostic and prognostic value of comparative thymidine kinase 1 (TK1) activity assays in breast cancer patient serum.
Complete remission in a BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma treated with cisplatin.
Autologous vaccine-induced antitumor and self-reactive immune responses in melanoma: impact on patient survival and dependence on MHC class II expression.
Israeli Society of Clinical Oncology
Israel Medical Association
Cancer Genetics Research Foundation Award
Landau Prize
Judith Segal Memorial Award
Oncology:
Head and neck tumors
Thyroid cancer
Personalized biological and immunotherapy
Treatment of recurrent cancer and spinal metastases
Radiotherapy
1998 — Graduated from the Faculty of Medicine at the Hebrew University (Jerusalem, Israel).
2016 — Six-month advanced training course in radiosurgery with a special focus on modern methods of focused radiotherapy for spinal and malignant thyroid tumors at Memorial Sloan Kettering Cancer Center (New York, USA).
1998–1999 — Internship at Hadassah University Hospital (Jerusalem, Israel).
1999–2005 — Specialization in the Department of Otolaryngology and Head & Neck Surgery at Rabin Medical Center (Petah Tikva, Israel).
2005–2009 — Specialization in oncology and radiotherapy at the Davidoff Cancer Center (Rabin Medical Center).
2006–2008 — Fellowship at the University of Michigan (Ann Arbor, USA) in multidisciplinary cancer treatment.
2008 — Fellowship in head and neck tumor brachytherapy at Beth Israel Medical Center (New York, USA).
2009–2012 — Head of the Head and Neck Oncology Clinic at the Davidoff Cancer Center.
2013–2019 — Chief of the Head and Neck Oncology Division and Deputy Head of the Radiotherapy Department at the Davidoff Cancer Center.
Since 2019 — Director of the Oncology Department and Sharett Cancer Institute at Hadassah University Hospital.
Oncogynecologist. Specialist in minimally invasive surgeries
Hip and Knee Replacement Specialist
Prof. Peled is a leading specialist in lung cancer immunotherapy, with expertise in Internal Medicine, Pulmonology and Medical Oncology. He has received the ASCO Merit Award, and is the head of the Thoracic Cancer Unit at Davidoff Cancer Center and Head of the Research and Detection Unit for Thoracic malignancies at Sheba Medical Center. He is a member of the Thoracic Oncology Assembly of the European Respiratory Society and Chair of the Early Detection and Prevention Committee of the International Association for the Study of Lung Cancer.
Urologist, Surgeon